|Bid||1.47 x 1200|
|Ask||1.48 x 1400|
|Day's Range||1.4300 - 1.6300|
|52 Week Range||1.1300 - 4.5200|
|Beta (3Y Monthly)||1.35|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 28, 2017 - Jul 31, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.33|
Premier Health Group (OTC:PHGRF) (CSE:PHGI), Teligent Inc (TLGT), Inovio Pharmaceuticals Inc (INO), and Aurora Cannabis Inc (NYSE: ACB, TSX: ACB) are 4 pharma stocks to keep tabs on as the industry moves toward the future. Premier Health Group (OTC:PHGRF) (CSE:PHGI), a company that you may not have heard of, but could potentially benefit from looking into, recognizes the importance of investing in the future of the pharmaceutical industry, and amid this understanding, has made key acquisitions and investments over the last few months to assure the best quality of products/care options for their patients. Premier Health Group (OTC:PHGRF) (CSE:PHGI) today announced it is moving forward with a binding Letter of Intent ("LOI") to acquire two Metro Vancouver-based pharmacies.
Shares of Teligent, Inc. shot up 12% in premarket trade Thursday after the company announced the U.S. Food and Drug Administration had approved the company's abbreviated new drug application for a generic 0.05% solution of clobetasol propionate ointment, a topical steroid used to treat skin irritation. The company said it plans to launch the product sometime this month and that the total addressable market for the product is approximately $70.5 million, according to data from November from IQVIA . Shares of Teligent have gained 23% in the year to date through Wednesday, while the S&P 500 has gained 5.3%.
BUENA, N.J., Jan. 24, 2019 -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the.
BUENA, N.J., Jan. 02, 2019 -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the.
BUENA, N.J., Dec. 13, 2018 -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that on December 13, 2018 the Company entered into a definitive first.
NEW YORK, Dec. 03, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
On a per-share basis, the Buena, New Jersey-based company said it had a loss of 7 cents. Earnings, adjusted for non-recurring costs and stock option expense, came to less than 1 cent on a per-share basis. ...
Teligent (TLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you own shares in Teligent Inc (NASDAQ:TLGT) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of Read More...
TORONTO , Aug. 14, 2018 /CNW/ - Teligent, Inc. (TLGT) ("Teligent"), a specialty generic pharmaceutical company, averted a national sterile water and sodium chloride crisis by securing inventory to cover 100% of the Canadian Market following a breakdown in the global supply chain. The hurricanes that hit Puerto Rico this past fall damaged one of the largest sterile water and sodium chloride supplier's manufacturing plants, crippling supply and causing significant worldwide drug shortages. Sterile water and sodium chloride are essential components in the mixing of medications for injection.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 8) AstraZeneca plc (ADR) (NYSE: AZN ) Bio-Rad Laboratories, Inc. ...
Teligent (TLGT) delivered earnings and revenue surprises of -1900.00% and 4.34%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?